The clinical problem of the wheezy infant is becoming more common, hospital admissions for wheeze in children up to the age of four years having increased fourfold in the United Kingdom over the last two decades. The financial implications of this rising morbidity in an overburdened health service is considerable, and the paucity of evidence from controlled treatment trials on these children is a continuing source of frustration.
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A longstanding controversy in paediatric respiratory medicine is whether or not the airways of infants contain functional 12 
